IMU-935 - Immunic
IMU-935: Initiation of PART B of P1 trial in healthy volunteers in Q3 2020 (Immunic Therapeutics) - May 28, 2020 - R&D Day: Initiation of PART C of P1 trial for moderate-to-severe psoriasis in H2 2020 
Trial status Psoriasis
http://ir.imux.com/events-and-presentations?item=36
 
May 28, 2020
 
 
2be77a0e-21c2-41b9-81df-e49d0dc88b28.png